Prevalence
Clinical
features
Differential
Diagnosis
Investigations
Therapy
Prevention
Prognosis
|  |  | | Therapy |
Give systemic steroids
a
Why?
-
Steroids help reduce length of hospital stay (on average by a day)
a
and improve respiratory function (increasing FEV1 on average by
120 l/min at 72 hours (95% CI: 50 to 190), but not
thereafter)
a
,
-
Steroids reduce treatment failure, but do not clearly reduce deaths.
a
-
However steroids commonly cause adverse-effects a
, particularly diabetes.
a
Steroids reduce treatment failure but cause
adverse effects
| Patient |
Treatment |
Comparison |
Outcome |
CER |
OR (95% CI) |
NNH
(95% CI) |
acute exacerbation of COPD
a
|
systemic
steroids
|
placebo
|
treatment failure
at days
|
29%
|
0.50
(0.32 to 0.79)
|
8
(6 to 22)
|
|
|
|
|
adverse effects
at days
|
25%
|
2.70
(1.72 to 4.23)
|
-5
(-9 to -2)
|
Steroids cause hyperglycaemia
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR (95% CI) |
NNH
(95% CI) |
acute exacerbation of COPD
a
|
steroids for 2 or 8 weeks
|
placebo
|
hyperglycaemia
at
weeks
|
4%
|
-316%
(-1066% to
-49%)
|
9
(6 to
21)
|
|